These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Advance in the research and discovery of novel drugs based on chemogenomics]. He BK; Ma ZC; Wang YG; Gao Y Yao Xue Xue Bao; 2008 Nov; 43(11):1077-81. PubMed ID: 19239023 [TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
5. Implications of pharmacogenomics for drug development. Kirk RJ; Hung JL; Horner SR; Perez JT Exp Biol Med (Maywood); 2008 Dec; 233(12):1484-97. PubMed ID: 18849536 [TBL] [Abstract][Full Text] [Related]
6. Chemogenomics in drug discovery. Kubinyi H Ernst Schering Res Found Workshop; 2006; (58):1-19. PubMed ID: 16708995 [TBL] [Abstract][Full Text] [Related]
7. Alternative strategies in drug development: clinical pharmacological aspects. Kuhlmann J Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949 [TBL] [Abstract][Full Text] [Related]
8. Discovery on Target 2006 - CHI's fourth annual event. Chemogenomics: small molecules as biological probes. Murphy M IDrugs; 2007 Jan; 10(1):30-2. PubMed ID: 17187311 [No Abstract] [Full Text] [Related]
9. Chemogenomics: drug discovery's panacea? Jacoby E Mol Biosyst; 2006 May; 2(5):218-20. PubMed ID: 16880939 [TBL] [Abstract][Full Text] [Related]
10. Optimizing the impact of genomics on drug discovery and development. Crooke ST Nat Biotechnol; 1998 May; 16 Suppl():29-30. PubMed ID: 9591260 [No Abstract] [Full Text] [Related]
11. Biomarkers: a valuable tool in clinical research and medical practice. Carini C IDrugs; 2007 Jun; 10(6):395-8. PubMed ID: 17642003 [TBL] [Abstract][Full Text] [Related]
12. Antibacterial drug discovery: is small pharma the solution? Boggs AF; Miller GH Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():32-6. PubMed ID: 15522038 [TBL] [Abstract][Full Text] [Related]
13. Looking forward in pharmaceutical process chemistry. Davies IW; Welch CJ Science; 2009 Aug; 325(5941):701-4. PubMed ID: 19661417 [TBL] [Abstract][Full Text] [Related]
14. A decade of fragment-based drug design: strategic advances and lessons learned. Hajduk PJ; Greer J Nat Rev Drug Discov; 2007 Mar; 6(3):211-9. PubMed ID: 17290284 [TBL] [Abstract][Full Text] [Related]
15. The impact of assay technology as applied to safety assessment in reducing compound attrition in drug discovery. Thomas CE; Will Y Expert Opin Drug Discov; 2012 Feb; 7(2):109-22. PubMed ID: 22468913 [TBL] [Abstract][Full Text] [Related]
16. The use of genomics in clinical trial design. Simon R Clin Cancer Res; 2008 Oct; 14(19):5984-93. PubMed ID: 18829477 [TBL] [Abstract][Full Text] [Related]
18. Chemical genomics: a systematic approach in biological research and drug discovery. Zheng XF; Chan TF Curr Issues Mol Biol; 2002 Apr; 4(2):33-43. PubMed ID: 11931568 [TBL] [Abstract][Full Text] [Related]
19. Will genomics revolutionise pharmaceutical R&D? Noble D Trends Biotechnol; 2003 Aug; 21(8):333-7. PubMed ID: 12902169 [TBL] [Abstract][Full Text] [Related]
20. Drug discovery alliances. Jones A; Clifford L Nat Rev Drug Discov; 2005 Oct; 4(10):807-8. PubMed ID: 16237845 [No Abstract] [Full Text] [Related] [Next] [New Search]